scispace - formally typeset
D

David Baltimore

Researcher at California Institute of Technology

Publications -  882
Citations -  168784

David Baltimore is an academic researcher from California Institute of Technology. The author has contributed to research in topics: RNA & Virus. The author has an hindex of 203, co-authored 876 publications receiving 162955 citations. Previous affiliations of David Baltimore include Thomas Jefferson University & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.

TL;DR: Findings indicate that the ATM gene product plays an essential role in a diverse group of cellular processes, including meiosis, the normal growth of somatic tissues, immune development, and tumor suppression.
Journal ArticleDOI

Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses

TL;DR: It is reported that miR-146a, one of the miRNAs prevalently expressed in Treg cells, is critical for their suppressor function and that an optimal range of Stat1 activation is important for Treg-mediated control of Th1 responses and associated autoimmunity.
Journal ArticleDOI

Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo

TL;DR: It is demonstrated that MyoD, in conjunction with E12/E47-like proteins, is functioning as a regulatory nodal point for activation of several other downstream muscle regulators.
Journal ArticleDOI

The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene.

TL;DR: By analogy to the gag/abl fusion protein of Abelson murine leukemia virus, the replacement of amino terminal c-abl sequences by bcr sequences in P210 may create a transforming protein involved in CML.
Journal ArticleDOI

MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell Development

TL;DR: It is shown that one aspect of miR-155 function is the promotion of T cell-dependent tissue inflammation, suggesting that miR -155 might be a promising therapeutic target for the treatment of autoimmune disorders.